Insider · CIK 0001845080
Philina Lee
Files at BPMC (Blueprint Medicines Corp). First filing Mar 7, 2025, latest Mar 7, 2025.
Philina Lee files SEC Form 4 as officer at BPMC (Blueprint Medicines Corp). Since Mar 7, 2025, Philina Lee has reported 0 open-market buys worth $0 and 1 open-market sell worth $331k, the latest filed on Mar 7, 2025.
A track record needs three past buys with six months of prices behind them; Philina Lee has 0, so none is measured yet.
The newest scored trade: sold $331k of BPMC on Mar 5, 2025, filed Mar 7, 2025, scored 45 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Blueprint Medicines Corp | $331k 3,733 shares | -8% | - |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +21,353 | - | - | 63,349 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Common Stock | -50,165 | - | - | 13,184 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | UTender of shares Common Stock | -13,184 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,650 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -6,928 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,669 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -22,000 | - | - | 0 | Jul 21, 2025 |
| Mar 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -3,733 | $88.80 | $331k | 41,996 | Mar 7, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +11,000 | $0.00 | $0 | 45,729 | Mar 4, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Mar 4, 2025 |
Questions about Philina Lee
Answered from the filings on this page, as of the latest one.
Is Philina Lee buying or selling?
Not in the last 12 months. Philina Lee's latest open-market trade on SEC Form 4 was sold $331k of BPMC on Mar 5, 2025.
How did Philina Lee's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Philina Lee has 0.
Where does Philina Lee file Form 4?
Philina Lee has filed Form 4 at BPMC (Blueprint Medicines Corp) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.